CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Zhen Marianne Chief Accounting Officer | Grant or award | +10,752 | $14.88 | $160K | 47,566 |
| 2024-03-05 | Zhen Marianne Chief Accounting Officer | Grant or award · Non-statutory Stock Option | +23,022 | 63,022 | ||
| 2024-03-05 | Raifeld Pavel Chief Executive Officer | Grant or award · Non-statutory Stock Option | +75,000 | 575,000 | ||
| 2024-03-05 | Raifeld Pavel Chief Executive Officer | Grant or award · Non-statutory Stock Option | +100,000 | 675,000 | ||
| 2024-03-05 | Raifeld Pavel Chief Executive Officer | Grant or award · Non-statutory Stock Option | +150,000 | 825,000 | ||
| 2024-02-20 | Ronsheim Matthew See Remarks | Shares withheld for taxes | −807 | $15.80 | $13K | 28,010 |
| 2024-02-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −2,862 | $15.80 | $45K | 36,814 |
| 2024-01-18 | Ronsheim Matthew See Remarks | Shares withheld for taxes | −1,600 | $16.05 | $26K | 28,817 |
| 2024-01-18 | Ronsheim Matthew See Remarks | Grant or award · Nonqualified Stock Option | +60,000 | 93,100 | ||
| 2023-11-20 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −784 | $13.62 | $11K | 39,676 |
| 2023-11-15 | Zhen Marianne Chief Accounting Officer | Grant or award | +302 | 40,460 | ||
| 2023-11-15 | Zhen Marianne Chief Accounting Officer | Sale | −5,589 | $14.01 | $78K | 45,563 |
| 2023-11-15 | Zhen Marianne Chief Accounting Officer | Sale | −5,405 | $13.97 | $76K | 40,158 |
| 2023-08-31 | Basso Stephen Chief Financial Officer | Grant or award · Nonqualified Stock Option | +150,000 | 150,000 | ||
| 2023-08-18 | Zhen Marianne Chief Accounting Officer | Shares withheld for taxes | −785 | $13.64 | $11K | 51,152 |
| 2023-07-31 | Koziel Margaret Chief Medical Officer | Grant or award · Nonqualified Stock Option | +60,000 | 60,000 | ||
| 2023-06-15 | DENNER ALEXANDER J 10% owner | Purchase | +62,000 | $13.13 | $814K | 7,277,000 |
| 2023-06-06 | DENNER ALEXANDER J 10% owner | Purchase | +8,000 | $13.05 | $104K | 7,215,000 |
| 2023-06-05 | DENNER ALEXANDER J 10% owner | Purchase | +7,000 | $13.04 | $91K | 7,207,000 |
| 2023-05-30 | DENNER ALEXANDER J 10% owner | Purchase | +120,000 | $13.01 | $1.6M | 7,200,000 |
Page 5 of 10 · 181 trades